Exploiting Lymphatic Transport for Early Detection

2020 Emerging Leader Award

Amanda Lund, PhD, New York University

Dr. Lund is developing a novel method for the early detection of tumor progression by focusing on biomarkers that are trafficked through the lymphatic system. Researchers in her laboratory are working to confirm that lymphatic vessels filter proteins secreted by tumors and that those secreted proteins are a rich source of cancer biomarkers. This research, initially focused on melanoma, will also determine whether proteins secreted into the lymph play a role in the early stages of tumor spreading and immune suppression. Dr. Lund earned a PhD from Rensselaer Polytechnic Institute and completed postdoctoral training at the Swiss Federal Institute of Technology Lausanne. Dr. Lund is an Associate Professor in the Ronald O. Perelman Department of Dermatology at NYU Langone Health.

published research

Steele MM, Lund AW. Afferent Lymphatic Transport and Peripheral Tissue Immunity. J Immunol. 2021.

Du Bois H, Heim TA, Lund AW. Tumor-draining lymph nodes: At the crossroads of metastasis and immunity. Sci Immunol. 2021.